ATE275973T1 - Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten - Google Patents

Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten

Info

Publication number
ATE275973T1
ATE275973T1 AT00928611T AT00928611T ATE275973T1 AT E275973 T1 ATE275973 T1 AT E275973T1 AT 00928611 T AT00928611 T AT 00928611T AT 00928611 T AT00928611 T AT 00928611T AT E275973 T1 ATE275973 T1 AT E275973T1
Authority
AT
Austria
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
AT00928611T
Other languages
English (en)
Inventor
Gary S Grubb
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Horace A Fletcher
Jay E Wrobel
Andrew Fensome
Puwen Zhang
Eugene A Terefenko
Original Assignee
Wyeth Corp
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth Corp, Ligand Pharm Inc filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE275973T1 publication Critical patent/ATE275973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT00928611T 1999-05-04 2000-05-01 Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten ATE275973T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators
PCT/US2000/011643 WO2000066164A1 (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Publications (1)

Publication Number Publication Date
ATE275973T1 true ATE275973T1 (de) 2004-10-15

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00928611T ATE275973T1 (de) 1999-05-04 2000-05-01 Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten

Country Status (14)

Country Link
EP (1) EP1173210B1 (de)
JP (1) JP2002543155A (de)
CN (1) CN1179753C (de)
AT (1) ATE275973T1 (de)
AU (1) AU4682000A (de)
CA (1) CA2372773A1 (de)
DE (1) DE60013798T2 (de)
DK (1) DK1173210T3 (de)
ES (1) ES2226833T3 (de)
HK (1) HK1043736B (de)
MX (1) MXPA01011311A (de)
PT (1) PT1173210E (de)
SI (1) SI1173210T1 (de)
WO (1) WO2000066164A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1699A (en) 2001-03-21 2006-12-26 Warner Lambert Co New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EP1551845A1 (de) 2002-10-11 2005-07-13 Ligand Pharmaceuticals, Inc. 5-CYCLOALKENYLç5H!CHROMENOç3,4-F!CHINOLINDERIVATE ALS SELEKTIVE, DEN PROGESTERONREZEPTOR MODULIERENDE VERBINDUNGEN
AU2003258047A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO(3,4-f)QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
AR047398A1 (es) 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
CA2563063C (en) * 2004-04-27 2014-06-03 Wyeth Purification of progesterone receptor modulators
WO2006010142A2 (en) 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
CA2205897A1 (en) * 1994-11-22 1996-05-30 Malcolm Cecil Pike Compositions and methods for contraception and for treatment of benign gynecological disorders
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ES2174265T3 (es) * 1996-06-25 2002-11-01 Akzo Nobel Nv Regimenes de progestogeno-anti-progestogeno.

Also Published As

Publication number Publication date
PT1173210E (pt) 2005-01-31
AU4682000A (en) 2000-11-17
WO2000066164A1 (en) 2000-11-09
DE60013798T2 (de) 2005-09-29
SI1173210T1 (en) 2005-02-28
WO2000066164A8 (en) 2001-05-03
CN1179753C (zh) 2004-12-15
EP1173210B1 (de) 2004-09-15
DK1173210T3 (da) 2005-01-24
DE60013798D1 (de) 2004-10-21
CA2372773A1 (en) 2000-11-09
CN1349415A (zh) 2002-05-15
EP1173210A1 (de) 2002-01-23
JP2002543155A (ja) 2002-12-17
ES2226833T3 (es) 2005-04-01
HK1043736A1 (en) 2002-09-27
HK1043736B (en) 2005-04-01
MXPA01011311A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
DK1175398T3 (da) Indolinderivater som progesteronantagonister
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
HUP0100266A2 (hu) NMDA-receptor-antagonista hatású 1-aminoalkilciklohexánszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és előállításaik
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
ITRM20010356A1 (it) "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
AR034203A1 (es) Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
WO2000066103A3 (en) Contraceptive compositions containing cyclic urea and amide derivatives
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
DE60013798D1 (de) Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
AR034350A1 (es) Indazoles e indoles fusionados, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento para el tratamiento de glaucoma
BR9811769A (pt) Tetraidro gama-carbolinas
BR0010214A (pt) Derivados de ciclotiocarbamato como moduladores de receptores de progesterona
DE602005019905D1 (de) -modulatoren
TR200002831A2 (tr) Kinolin-4-İl türevleri I
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators
EA200101180A1 (ru) Производные тио-оксиндола
DK1809602T3 (da) Indolderivater, der kan anvendes som progesteronreceptormodulatorer
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173210

Country of ref document: EP

REN Ceased due to non-payment of the annual fee